kyowa kirin international
Galashiels
Our vision is to be a global specialty pharmaceutical company, contributing to
human health and wellbeing worldwide through innovative drug discovery and
global commercialisation. This work will be driven by leading-edge antibody
technologies in the core therapeutic areas of oncology, nephrology,
immunology/allergy and the central nervous system. We are currently focussing on
launching pipeline products originated by Kyowa Kirin in Europe and the United
States.